Bibliography for: "Patient/pharmacist connection is root of Kerr future success"

James Frederick "Patient/pharmacist connection is root of Kerr future success". Drug Store News. FindArticles.com. 29 Nov, 2009. http://findarticles.com/p/articles/mi_m3374/is_10_24/ai_90623441/

Drug Store News

View more issues:

Articles in August 12, 2002 issue of Drug Store News

• It's the end of the line as Phar-Mor closes its doors
  by Liz Parks
• Sour makes for sweet sales as brands launch tart candies
  by Rob Eder
• Medicare reform tops list of chain pharmacy's woes
  by James Frederick
• Stop & Shop combines Speedpass, loyalty card
• Kmart
• What's good for pharmacy is good for health care
  by Mark Griffin
• FDA OKs innotech skin-perforator
• Women's need for total beauty revives nail care category sales
  by Molly Prior
• Hershey Foods
• Ranbaxy and Teva also received FDA approval for lisinopril and hydrochiorothiazide tablets in 10 mg/12.5 mg, 20 mg/12.5 mg and 20 mg/25 mg
• Behind the blurry outlines, HIPAA privacy rules loom
  by James Frederick
• Snyder's strengthens pharmacy muscle
  by James Frederick
• Inverness Medical
• H-E-B to open more ethnic stores
  by Liz Parks
• FDA OKs Amgen's Aranesp
• Novartis
• Schiff extends Move Free line
• Virgin Mobile
• Pfizer acquisition of Pharmacia will unite drug power players
• Chains garner some success in bid for reimbursement
  by Lori C. Brown
• Chains lead drive toward e-prescribing standard
  by Liz Parks
• Northwest Natural Products
• HHS' Thompson seeks to cover kids
• Duane Reade reports lax 2Q sales
  by Antoinette Alexander
• Longs Drug Stores
• M is for Massachusetts, Medicaid and mail order
  by Rob Eder
• Unilever launches first-aid Q-tips
• New Dana Perfumes Corp
• Frito-Lay North America will add two new flavors to its Go Snacks line at the end of the third quarter, the company announced
• Eon Labs received approval for Lisinopril/HCTZ, the generic version of Merck & Co.'s hypertension treatment Prinzide
• Medicare reform continues to be among pharmacy's top concerns
  by Al Heller
• Patient/pharmacist connection is root of Kerr future success
  by James Frederick
• Gaiam
• Diabetes Update
• CVS momentum going strong in second quarter
• Wegmans shifts pricing to EDLP strategy
• Merck postpones Medco IPO
• Target earlier this month overhauled its entire line of dietary supplements, consisting of more than 115 individual SKUs, and renamed the line Origin, a supplier source told Drug Store News
• McKesson honors Home Diagnostics
• Phthalates has industry taking sides
• Campbell Soup
• Eon Labs
• Automation drives pharmacy to increased profits, efficiencies
  by Liz Parks
• Longs hones efficiency with central fill
  by Doug Desjardins
• Mason Vitamins
• Grass motions to drop judge
• Rite Aid launches women's magazine
• Former Eckerd vice chairman Robert Hannan has joined the board of TechRx
• Industry unwilling to give an inch to gain a mile
  by Mark Tosh
• Take your vitamins
• Revlon
• Wal-Mart
• Upsher-Smith Laboratories
• Top 50 chains in pharmacy dollar volume
• Eckerd expands thriving pharmacy strategy
  by Mike Troy
• Amerifit Nutrition
• Windmill Health Products
• Senate kills Rx bills; NACDS to support Together Rx plan
• Pathmark, N.Y. union hammer out deal
• FTC wants Hatch-Waxman changes
• In this market, we all become worriers
  by Meredith Adler
• Kundtz named CNS vice president
• Drug goes hip to grab 'tweens
• Coca-Cola
• Mylan
• Pharmacist shortage continues as chains compete to fill posts
  by Saskia D. De Caires
• Care comes before paperwork at Brooks
  by Antoinette Alexander
• Jamieson Laboratories
• Technology, better promos boost Long's front end
  by Doug Desjardins
• Giant Eagle ramps up central fill
  by Liz Parks
• DrSN's Bennett promoted to national sales manager
• Pfizer
• FDA and JAMA raise eyebrows at efficacy of head lice remedies
• Inkworks
• Whitening brightens up gum sales
• AmerisourceBergen buyout of AutoMed adds automation to distribution arsenal
• Chains sharpen pharmacy efficiencies with technology and new designs
  by Rob Eder
• Tough times unite natural health market
  by Rob Eder
• NutraMax Laboratories
• Canadian chain performance earns kudos from analysts
  by Michael Johnsen

• 1
• 2